Cargando…
Analytical Challenges and Regulatory Requirements for Nasal Drug Products in Europe and the U.S.
Nasal drug delivery can be assessed by a variety of means and regulatory agencies, e.g., the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have published a set of guidelines and regulations proposing in vitro test methods for the characterization of nasal drug products....
Autores principales: | Trows, Sabrina, Wuchner, Klaus, Spycher, Rene, Steckel, Hartwig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085595/ https://www.ncbi.nlm.nih.gov/pubmed/24732068 http://dx.doi.org/10.3390/pharmaceutics6020195 |
Ejemplares similares
-
Comparison of Current Regulatory Status for Gene-Based Vaccines in the U.S., Europe and Japan
por: Nakayama, Yoshikazu, et al.
Publicado: (2015) -
Europe pulls ahead of U.S. in physics
Publicado: (2008) -
Public Debt Dynamics of Europe and the U.S
por: Chorafas, Dimitris
Publicado: (2013) -
Requirements and Study Designs for U.S. Regulatory Approval of Influenza Home Tests
por: Yang, Tony, et al.
Publicado: (2022) -
Europe 3, U.S. not even Z-Zero
Publicado: (1983)